Linvoseltamab Generates Efficacy Similar to That Seen With Teclistamab in R/R Myeloma

Linvoseltamab elicited outcomes equivalent to those seen with teclistamab in patients with triple-class exposed relapsed/refractory multiple myeloma.

Related Keywords

Sundar Jagannath ,Mount Sinai Tisch Cancer Institute ,European Hematology Association ,Multiple Myeloma ,